Bobcatbio
Developer of cancer-specific immunotherapy designed for the treatment of solid tumors. The company employs an adoptive cell therapy approach to elicit tumor-specific T-cells, resulting in a polyclonal...
Valuation
$51M
Market implied
Share Price
N/A
Total Raised
$32.4M
Last Round
N/A